Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …
BSE India
Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q3 of FY23 Earnings Call held on January 25, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.